Your browser doesn't support javascript.
loading
Application of a nonrandomized stepped wedge design to evaluate an evidence-based quality improvement intervention: a proof of concept using simulated data on patient-centered medical homes.
Huynh, Alexis K; Lee, Martin L; Farmer, Melissa M; Rubenstein, Lisa V.
Afiliación
  • Huynh AK; VA Greater Los Angeles HSR&D Center for the Study of Healthcare Innovation, Implementation & Policy (CSHIIP), 16111 Plummer St, Bldg 25, North Hills, CA, 91343, USA. alexis.huynh@va.gov.
  • Lee ML; VA Greater Los Angeles HSR&D Center for the Study of Healthcare Innovation, Implementation & Policy (CSHIIP), 16111 Plummer St, Bldg 25, North Hills, CA, 91343, USA.
  • Farmer MM; UCLA Fielding School of Public Health, 405 Hilgard Ave, Los Angeles, CA, 90024, USA.
  • Rubenstein LV; VA Greater Los Angeles HSR&D Center for the Study of Healthcare Innovation, Implementation & Policy (CSHIIP), 16111 Plummer St, Bldg 25, North Hills, CA, 91343, USA.
BMC Med Res Methodol ; 16(1): 143, 2016 10 21.
Article en En | MEDLINE | ID: mdl-27769177
ABSTRACT

BACKGROUND:

Stepped wedge designs have gained recognition as a method for rigorously assessing implementation of evidence-based quality improvement interventions (QIIs) across multiple healthcare sites. In theory, this design uses random assignment of sites to successive QII implementation start dates based on a timeline determined by evaluators. However, in practice, QII timing is often controlled more by site readiness. We propose an alternate version of the stepped wedge design that does not assume the randomized timing of implementation while retaining the method's analytic advantages and applying to a broader set of evaluations. To test the feasibility of a nonrandomized stepped wedge design, we developed simulated data on patient care experiences and on QII implementation that had the structures and features of the expected data from a planned QII. We then applied the design in anticipation of performing an actual QII evaluation.

METHODS:

We used simulated data on 108,000 patients to model nonrandomized stepped wedge results from QII implementation across nine primary care sites over 12 quarters. The outcome we simulated was change in a single self-administered question on access to care used by Veterans Health Administration (VA), based in the United States, as part of its quarterly patient ratings of quality of care. Our main predictors were QII exposure and time. Based on study hypotheses, we assigned values of 4 to 11 % for improvement in access when sites were first exposed to implementation and 1 to 3 % improvement in each ensuing time period thereafter when sites continued with implementation. We included site-level (practice size) and respondent-level (gender, race/ethnicity) characteristics that might account for nonrandomized timing in site implementation of the QII. We analyzed the resulting data as a repeated cross-sectional model using HLM 7 with a three-level hierarchical data structure and an ordinal outcome. Levels in the data structure included patient ratings, timing of adoption of the QII, and primary care site.

RESULTS:

We were able to demonstrate a statistically significant improvement in adoption of the QII, as postulated in our simulation. The linear time trend while sites were in the control state was not significant, also as expected in the real life scenario of the example QII.

CONCLUSIONS:

We concluded that the nonrandomized stepped wedge design was feasible within the parameters of our planned QII with its data structure and content. Our statistical approach may be applicable to similar evaluations.
Asunto(s)
Palabras clave

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Práctica Clínica Basada en la Evidencia Tipo de estudio: Clinical_trials / Prognostic_studies Límite: Humans Idioma: En Revista: BMC Med Res Methodol Asunto de la revista: MEDICINA Año: 2016 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Práctica Clínica Basada en la Evidencia Tipo de estudio: Clinical_trials / Prognostic_studies Límite: Humans Idioma: En Revista: BMC Med Res Methodol Asunto de la revista: MEDICINA Año: 2016 Tipo del documento: Article País de afiliación: Estados Unidos